BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32105409)

  • 21. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital.
    Yao H; Jiang F; Hu H; Gao Y; Zhu Z; Zhang H; Wang Y; Guo Y; Liu L; Yuan Y; Zhou L; Wang J; Du B; Qu N; Zhang R; Dong Y; Xu H; Chen F; Jiang H; Liu Y; Zhang L; Tian Z; Liu Q; Zhang C; Pan X; Yang S; Zhao L; Wang W; Liang Z
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):17-24. PubMed ID: 24616044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis and annotation of whole-genome or whole-exome sequencing-derived variants for clinical diagnosis.
    Worthey EA
    Curr Protoc Hum Genet; 2013 Oct; 79():9.24.1-9.24.24. PubMed ID: 24510652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How novel molecular diagnostic technologies and biomarkers are revolutionizing genetic testing and patient care.
    Baudhuin LM; Donato LJ; Uphoff TS
    Expert Rev Mol Diagn; 2012 Jan; 12(1):25-37. PubMed ID: 22133117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma.
    Wong FC; Lo YM
    Annu Rev Med; 2016; 67():419-32. PubMed ID: 26473414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of mosaicism at blastocyst stage with the use of high-resolution next-generation sequencing.
    Munné S; Wells D
    Fertil Steril; 2017 May; 107(5):1085-1091. PubMed ID: 28390692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New approaches to molecular diagnosis.
    Korf BR; Rehm HL
    JAMA; 2013 Apr; 309(14):1511-21. PubMed ID: 23571590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq).
    Johnson SH; Smadbeck JB; Smoley SA; Gaitatzes A; Murphy SJ; Harris FR; Drucker TM; Zenka RM; Pitel BA; Rowsey RA; Hoppman NL; Aypar U; Sukov WR; Jenkins RB; Feldman AL; Kearney HM; Vasmatzis G
    Cancer Genet; 2018 Feb; 221():1-18. PubMed ID: 29405991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analyses.
    Yan L; Huang L; Xu L; Huang J; Ma F; Zhu X; Tang Y; Liu M; Lian Y; Liu P; Li R; Lu S; Tang F; Qiao J; Xie XS
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15964-9. PubMed ID: 26712022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-read sequencing for rare human genetic diseases.
    Mitsuhashi S; Matsumoto N
    J Hum Genet; 2020 Jan; 65(1):11-19. PubMed ID: 31558760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13.
    Tynan JA; Kim SK; Mazloom AR; Zhao C; McLennan G; Tim R; Liu L; Hannum G; Hull A; Bombard AT; Oeth P; Burcham T; van den Boom D; Ehrich M
    Prenat Diagn; 2016 Jan; 36(1):56-62. PubMed ID: 26505614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-generation sequencing - feasibility and practicality in haematology.
    Kohlmann A; Grossmann V; Nadarajah N; Haferlach T
    Br J Haematol; 2013 Mar; 160(6):736-53. PubMed ID: 23294427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition.
    Ku CS; Cooper DN; Iacopetta B; Roukos DH
    Clin Genet; 2013 Jan; 83(1):2-6. PubMed ID: 23020236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Overview on Prenatal Screening for Chromosomal Aberrations.
    Hixson L; Goel S; Schuber P; Faltas V; Lee J; Narayakkadan A; Leung H; Osborne J
    J Lab Autom; 2015 Oct; 20(5):562-73. PubMed ID: 25587000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next-Generation Sequencing to Diagnose Suspected Genetic Disorders.
    Adams DR; Eng CM
    N Engl J Med; 2018 Oct; 379(14):1353-1362. PubMed ID: 30281996
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic analysis of Charcot-Marie-Tooth disease in Denmark and the implementation of a next generation sequencing platform.
    Vaeth S; Christensen R; Dunø M; Lildballe DL; Thorsen K; Vissing J; Svenstrup K; Hertz JM; Andersen H; Jensen UB
    Eur J Med Genet; 2019 Jan; 62(1):1-8. PubMed ID: 29653220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing.
    Cohen K; Tzika A; Wood H; Berri S; Roberts P; Mason G; Sheridan E
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):394-401. PubMed ID: 25510919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next generation sequencing is here now.
    Erickson RP
    Lymphology; 2014 Dec; 47(4):196-7. PubMed ID: 25915980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-Molecule Sequencing: Towards Clinical Applications.
    Ameur A; Kloosterman WP; Hestand MS
    Trends Biotechnol; 2019 Jan; 37(1):72-85. PubMed ID: 30115375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.